Summit Therapeutics Inc.SMMTNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank93
3Y CAGR-13.5%
5Y CAGR+27.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-13.5%/yr
vs +77.4%/yr prior
5Y CAGR
+27.7%/yr
Recent deceleration
Acceleration
-90.9pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $225.27M | +114.8% |
| 2024 | $104.86M | +46.8% |
| 2023 | $71.42M | -79.5% |
| 2022 | $348.61M | +385.6% |
| 2021 | $71.79M | +8.1% |
| 2020 | $66.42M | +32.9% |
| 2019 | $49.96M | +41.8% |
| 2018 | $35.23M | +23.8% |
| 2017 | $28.45M | -18.9% |
| 2016 | $35.08M | - |